APA (7th ed.) Citation

R, T., LA, S., JC, P., & DE, G. (2020). Checkpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma. Leukemia & lymphoma, 61(1), 228. https://doi.org/10.1080/10428194.2019.1658104

Chicago Style (17th ed.) Citation

R, Thummalapalli, Sena LA, Probasco JC, and Gladstone DE. "Checkpoint Inhibitor-induced Autoimmune Encephalitis Reversed by Rituximab After Allogeneic Bone Marrow Transplant in a Patient with Hodgkin Lymphoma." Leukemia & Lymphoma 61, no. 1 (2020): 228. https://doi.org/10.1080/10428194.2019.1658104.

MLA (9th ed.) Citation

R, Thummalapalli, et al. "Checkpoint Inhibitor-induced Autoimmune Encephalitis Reversed by Rituximab After Allogeneic Bone Marrow Transplant in a Patient with Hodgkin Lymphoma." Leukemia & Lymphoma, vol. 61, no. 1, 2020, p. 228, https://doi.org/10.1080/10428194.2019.1658104.